1,3-Propanedisulfonic acid - CAS 21668-77-9
Catalog: |
BB017063 |
Product Name: |
1,3-Propanedisulfonic acid |
CAS: |
21668-77-9 |
Synonyms: |
propane-1,3-disulfonic acid |
IUPAC Name: | propane-1,3-disulfonic acid |
Description: | 1,3-Propanedisulfonic acid (CAS# 21668-77-9) is a useful research chemical. |
Molecular Weight: | 204.22 |
Molecular Formula: | C3H8O6S2 |
Canonical SMILES: | C(CS(=O)(=O)O)CS(=O)(=O)O |
InChI: | InChI=1S/C3H8O6S2/c4-10(5,6)2-1-3-11(7,8)9/h1-3H2,(H,4,5,6)(H,7,8,9) |
InChI Key: | MGNVWUDMMXZUDI-UHFFFAOYSA-N |
Density: | 1.773 g/cm3 |
Appearance: | Liquid |
MDL: | MFCD00191482 |
LogP: | 1.31370 |
GHS Hazard Statement: | H302 (90.48%): Harmful if swallowed [Warning Acute toxicity, oral]; H312 (90.48%): Harmful in contact with skin [Warning Acute toxicity, dermal]; H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]; H332 (90.48%): Harmful if inhaled [Warning Acute toxicity, inhalation] |
Precautionary Statement: | P260, P261, P264, P270, P271, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P362+P364, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2015168315-A1 | Use of 1,3-propanedisulfonic acid or pharmaceutically acceptable salts thereof for the treatment of sarcoidosis | 20140430 |
WO-2015110263-A1 | Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyolid-like proteins | 20140121 |
EP-2878702-A1 | Organic disulfide-containing surface treatment solution for gold or gold alloy plating and method thereof | 20131129 |
US-9080013-B2 | Production method for aliphatic polyester | 20130722 |
WO-2014170037-A1 | Functional chromium layer with improved corrosion resistance | 20130417 |
PMID | Publication Date | Title | Journal |
22197598 | 20120526 | [New trends in the treatment of amyloidosis] | Medicina clinica |
22528417 | 20120301 | Counterion condensation in short cationic peptides: limiting mobilities beyond the Onsager-Fuoss theory | Electrophoresis |
22427728 | 20120101 | Review of eprodisate for the treatment of renal disease in AA amyloidosis | International journal of nephrology and renovascular disease |
21562591 | 20111201 | Preclinical development of siRNA therapeutics for AL amyloidosis | Gene therapy |
21360109 | 20110801 | Renal amyloidosis in children | Pediatric nephrology (Berlin, Germany) |
Complexity: | 254 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 203.97623032 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 6 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 203.97623032 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 126 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -1.6 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Sulfur Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS